|
Volumn 365, Issue 6445, 1993, Pages 451-453
|
Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
ANTIVIRUS AGENT;
DIDANOSINE;
EMTRICITABINE;
LAMIVUDINE;
NEVIRAPINE;
RNA DIRECTED DNA POLYMERASE;
ZIDOVUDINE;
ARTICLE;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MULTIDRUG RESISTANCE;
NONHUMAN;
PRIORITY JOURNAL;
VIRUS MUTATION;
VIRUS REPLICATION;
BASE SEQUENCE;
DIDANOSINE;
DNA, VIRAL;
DRUG RESISTANCE, MICROBIAL;
HELA CELLS;
HIV-1;
HIV-1 REVERSE TRANSCRIPTASE;
HUMAN;
MOLECULAR SEQUENCE DATA;
MUTAGENESIS, SITE-DIRECTED;
NEVIRAPINE;
PYRIDINES;
REVERSE TRANSCRIPTASE INHIBITORS;
RNA-DIRECTED DNA POLYMERASE;
ZIDOVUDINE;
|
EID: 0027486945
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/365451a0 Document Type: Article |
Times cited : (140)
|
References (29)
|